Oncologist Co-Founds Startup to Guide AI Integration in Cancer Care
Dr. Douglas Flora, an oncologist based in Northern Kentucky (NKY), has co-founded TensorBlack, a startup designed to help oncologists and healthcare professionals navigate and integrate artificial intelligence (AI) into cancer care. The company offers curated information, educational resources, and a…

Cincinnati, OH, October 6, 2026 — Dr. Douglas Flora, an oncologist practicing in Northern Kentucky (NKY), has co-founded a new startup named TensorBlack. The company aims to assist oncologists and other healthcare professionals in understanding and implementing artificial intelligence (AI) technologies within the field of cancer care.
TensorBlack is positioned to address the growing complexity of AI advancements and their potential applications in oncology. The startup’s objective is to provide a structured approach for clinicians who are seeking to integrate these new tools into their practice but may lack the specialized knowledge or resources to do so effectively.
The company’s offerings are designed to support healthcare professionals through the evolving landscape of AI in medicine. Key components of TensorBlack’s support system include:
- Curated Information: Providing access to vetted and relevant information regarding AI developments in cancer care.
- Educational Resources: Developing and offering materials to help clinicians learn about AI concepts, tools, and their practical uses.
- Professional Community: Establishing a platform for oncologists and healthcare professionals to connect, share insights, and discuss challenges and opportunities related to AI in cancer treatment.
By facilitating access to tailored information and fostering a collaborative environment, TensorBlack seeks to empower medical professionals to make informed decisions about adopting AI technologies. The initiative underscores a broader trend of technology development focused on enhancing medical practice through data-driven insights and advanced computational tools.
The specific operational details, such as the launch date of TensorBlack or the extent of its current user base, were not provided in the summary. However, the company’s establishment highlights a dedicated effort to bridge the gap between cutting-edge AI research and its practical application at the point of care for cancer patients.
Story summarized from the original created by Kenton Hornbeck on linknky.com, see more information here.
Media gallery
